Cite
MLA Citation
Elliot Stieglitz et al.. “Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group.” Pediatric blood & cancer, vol. 62, no. 4, n.d., pp. 629–636. http://access.bl.uk/ark:/81055/vdc_100025131667.0x00000c